000100.KS Overview

Company Profile

Related stocks

128940.KS • South Korea

HanmiPharm

480,500 KRW

4.55B USD 1Y +35.5%

600329.SS • China

TIANJIN PHARMACEUTICAL DA REN T

35.8 CNY

4.13B USD 1Y -17.6%

002603.SZ • China

YILING

15.53 CNY

3.88B USD 1Y -4.1%

RGC • Hong Kong SAR China

Regencell Bioscience Holdings L

7.35 USD

3.64B USD 1Y -60.7%

4506.T • Japan

SUMITOMO PHARMA CO LTD

1,591.5 JPY

4.51B USD 1Y -15.7%

000661.SZ • China

CCHN

71.9 CNY

4.39B USD 1Y -44.4%

600079.SS • China

HUMANWELL HEALTHCARE (GROUP) CO

19.23 CNY

4.7B USD 1Y -10.1%

000739.SZ • China

APELOA PHARMA.

25.4 CNY

4.4B USD 1Y +55.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

South Korea

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

39.9% p.a.

Max Drawdown (5Y)

-59.4%

Sharpe Ratio (5Y)

0.12

Beta Factor

0.43

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (46.9%) is noticeably higher than the 5Y average (39.9%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (39.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -59.4% in the extended horizon.